Antineuronal autoantibodies in neurological disorders

Area of Science:

• Neurology
• Immunology
• Neuroimmunology

Background:

• Autoantibodies (abs) are crucial biomarkers in neurological diseases.
• Current classification divides abs based on target antigen location: intracellular (Group I) or neuronal cell membrane (Group II).

Purpose of the Study:

• To review and classify autoantibodies associated with neurological diseases.
• To provide an overview of the characteristics of each autoantibody group.
• To detail specific autoantibodies and their related clinical syndromes.

Main Methods:

• Literature review of autoantibodies in neurological disorders.
• Classification of autoantibodies into Group I (intracellular antigens) and Group II (cell membrane antigens).
• Analysis of diagnostic impact for paraneoplastic and non-paraneoplastic neurological diseases.

Main Results:

• Group I abs target intracellular antigens (e.g., Hu, Yo, Ri, GAD).
• Group II abs target neuronal cell membrane antigens (e.g., VGKC, NMDA-R, AMPA-R).
• Both groups are further subclassified by their relevance in paraneoplastic and non-paraneoplastic neurological conditions.

Conclusions:

• Understanding autoantibody classification aids in diagnosing neurological diseases.
• This classification aids in differentiating paraneoplastic from non-paraneoplastic neurological syndromes.
• Detailed knowledge of autoantibodies and their targets improves clinical management.